Stelara 45 MG/0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FP0VD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,399
Award facts
- Contract value 100% obligated
- $8,398.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on November 3, 2025, for the supply of Stelara 45 mg/0.5 ml syringes valued at $8,398.61. The contract, which utilizes firm fixed price terms with a completion date of November 4, 2025, represents a non-set-aside competitive award. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
The award reflects AmerisourceBergen's established role as a critical federal medical procurement vendor serving the Defense Health Agency and other government healthcare systems. Stelara is a specialty immunosuppressant medication used to treat various autoimmune and inflammatory conditions, and its inclusion in this delivery order demonstrates the company's capability to fulfill federal requirements for specialized pharmaceutical commodities. The DLA Troop Support Medical contract vehicle provides the operational framework for such transactions, allowing flexible procurement of pharmaceuticals and medical supplies across multiple therapeutic domains to support worldwide military healthcare operations.
Quick answers
Who was awarded contract SPE2DB26FP0VD?
SPE2DB26FP0VD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DB26FP0VD worth?
The government has obligated $8,399 on SPE2DB26FP0VD.
Is contract SPE2DB26FP0VD an order under another contract?
Yes. SPE2DB26FP0VD is a delivery order under SPE2DB22D3010, an indefinite delivery contract.
Was contract SPE2DB26FP0VD competed?
The extent of competition for SPE2DB26FP0VD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award